Literature DB >> 17166780

Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.

Malin Carlsson1, Leif Eriksson, Tania Pressler, Ragnhild Kornfält, Lena Mared, Peter Meyer, Allan Wiik, Jörgen Wieslander, Mårten Segelmark.   

Abstract

BACKGROUND: Autoantibodies against bactericidal permeability increasing protein (BPI-ANCA) are frequently present in cystic fibrosis patients and have been reported to be associated to colonization with Pseudomonas (P) aeruginosa and lung damage. In the present study, we investigated BPI-ANCA as a prognostic marker and its relation to P. aeruginosa colonization and lung function.
METHODS: BPI-ANCA, measured by ELISA, was examined relative to lung function and microbiological findings. The prognostic value of BPI-ANCA was assessed in 46 adult patients followed for 1.2-8.9 years. The cross-sectional investigation was performed in 366 patients (age 0.5-55).
RESULTS: The presence of BPI-ANCA predicted poor prognosis. An adverse outcome occurred in 15/28 BPI-ANCA positive patients and in 2/18 BPI-ANCA negative patients (p=0.01). This result remained valid when the patients were stratified according to lung function (p=0.03). Findings of BPI-ANCA were correlated to P. aeruginosa colonization and lung damage. Development of BPI-ANCA occurred after colonization with P. aeruginosa. All colonized patients did not develop BPI-ANCA. The BPI-ANCA levels were fairly stable during the disease course, but decreased significantly following lung transplantation.
CONCLUSION: BPI-ANCA responses follow colonization with P. aeruginosa and may be predictive for lung damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166780     DOI: 10.1016/j.jcf.2006.10.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  11 in total

Review 1.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

Review 2.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 3.  Anti-neutrophil cytoplasmic antibodies and their clinical significance.

Authors:  Supaporn Suwanchote; Muanpetch Rachayon; Pongsawat Rodsaward; Jongkonnee Wongpiyabovorn; Tawatchai Deekajorndech; Helen L Wright; Steven W Edwards; Michael W Beresford; Pawinee Rerknimitr; Direkrit Chiewchengchol
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

4.  Pseudomonas toxin pyocyanin triggers autophagy: Implications for pathoadaptive mutations.

Authors:  Zhong-Shan Yang; Lan-Qing Ma; Kun Zhu; Jin-Yuan Yan; Li Bian; Ke-Qin Zhang; Cheng-Gang Zou
Journal:  Autophagy       Date:  2016-05-09       Impact factor: 16.016

Review 5.  Prevalence of Bactericidal/Permeability-Increasing Protein Autoantibodies in Cystic Fibrosis Patients: Systematic Review and Meta-Analysis.

Authors:  Kenneth Iwuji; Eneko Larumbe-Zabala; Sharan Bijlani; Kenneth Nugent; Adaobi Kanu; Erena Manning; Ximena Solis
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-06-17       Impact factor: 1.349

6.  Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosis.

Authors:  Francis H C Tsao; Zhuzai Xiang; Adnan Abbasi; Keith C Meyer
Journal:  BMC Pulm Med       Date:  2012-08-17       Impact factor: 3.317

7.  BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.

Authors:  Ulrika Lindberg; Malin Carlsson; Thomas Hellmark; Mårten Segelmark
Journal:  J Immunol Res       Date:  2015-07-26       Impact factor: 4.818

8.  Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Authors:  Mary J Emond; Tin Louie; Julia Emerson; Jessica X Chong; Rasika A Mathias; Michael R Knowles; Mark J Rieder; Holly K Tabor; Debbie A Nickerson; Kathleen C Barnes; Lung Go; Ronald L Gibson; Michael J Bamshad
Journal:  PLoS Genet       Date:  2015-06-05       Impact factor: 5.917

9.  BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study.

Authors:  Ulrika Lindberg; Malin Carlsson; Claes-Göran Löfdahl; Mårten Segelmark
Journal:  Clin Dev Immunol       Date:  2012-12-30

Review 10.  Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.

Authors:  Daniel Söderberg; Mårten Segelmark
Journal:  Front Immunol       Date:  2016-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.